GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » Pretax Margin %

Syncom Formulation (India) (NSE:SYNCOMF) Pretax Margin % : 13.45% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Syncom Formulation (India)'s Pre-Tax Income for the three months ended in Mar. 2024 was ₹100 Mil. Syncom Formulation (India)'s Revenue for the three months ended in Mar. 2024 was ₹746 Mil. Therefore, Syncom Formulation (India)'s pretax margin for the quarter that ended in Mar. 2024 was 13.45%.

The historical rank and industry rank for Syncom Formulation (India)'s Pretax Margin % or its related term are showing as below:

NSE:SYNCOMF' s Pretax Margin % Range Over the Past 10 Years
Min: 6.97   Med: 8.97   Max: 17.01
Current: 12.89


NSE:SYNCOMF's Pretax Margin % is ranked better than
71.5% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 4.22 vs NSE:SYNCOMF: 12.89

Syncom Formulation (India) Pretax Margin % Historical Data

The historical data trend for Syncom Formulation (India)'s Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) Pretax Margin % Chart

Syncom Formulation (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.64 17.01 12.02 11.85 12.89

Syncom Formulation (India) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.86 10.22 13.24 14.37 13.45

Competitive Comparison of Syncom Formulation (India)'s Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syncom Formulation (India)'s Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s Pretax Margin % falls into.



Syncom Formulation (India) Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Syncom Formulation (India)'s Pretax Margin for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=339.53/2633.871
=12.89 %

Syncom Formulation (India)'s Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=100.3/745.729
=13.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syncom Formulation (India)  (NSE:SYNCOMF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Syncom Formulation (India) Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Syncom Formulation (India) (NSE:SYNCOMF) Business Description

Traded in Other Exchanges
Address
207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (NSE:SYNCOMF) Headlines

No Headlines